Impact Factor
4.27
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.78
5,636 total citations
h5-index
76
h5 depth signal
Cited share
82.9%
1,043 of 1,258
Total citations
5,636
Citation footprint
Metric signal
4.60
External metric anchor
Self-citation
2.7%
152 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
4,162
United Kingdom
737
China
609
Canada
375
Netherlands
365
Citing Fields of Research
Virology
2,152
Immunology
1,282
HIV
1,007
Tropical Diseases
749
Antibiotic & Antibacterial Agents
695
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
38,437
Articles tracked across the journal lifetime
Indexed publication set
1,258
1,043 cited publications
Last 12 months
655
54.6 publications/month
Open access share
45.3%
297 OA publications in the last year
Leading citing country
United States
4,162 citing publications
Leading citing field
Virology
2,152 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v115n4,Oct. 1965-
v115n4,Oct. 1965-
Active Coverage
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Virology
HIV
Antibiotic & Antibacterial Agents
Immunology
Mycobacterial Diseases
Parasitology Studies
Issuing & Sponsoring Bodies
Contributor
John McCormick Institute for Infectious Diseases
Contributor
John Rockefeller McCormick Memorial Fund
Contributor
Memorial Institute for Infectious Diseases (Chicago, Ill.)
Contributor
Infectious Diseases Society of America
Broad Categories
Communicable Diseases
Virology
HIV
Antibiotic & Antibacterial Agents
Tropical Diseases
Mycobacterial Diseases
Viral Identification & Phylogenetics
MeSH Descriptors
Communicable Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1093/infdis/jiag517
Open DOI
Experimental pneumococcal carriage reveals humoral correlates of susceptibility in virally suppressed adults with HIV
Background: People with HIV (PWH) in sub-Saharan Africa remain at high risk of pneumococcal carriage and disease, despite effective antiretroviral therapy. Understanding the immune factors driving this is key to addressing the issue. Met...
02
DOI 10.1093/infdis/jiag518
Open DOI
Rapid Differentiation of Vaccine and Wild-Type Measles Virus During an Ongoing Outbreak using a new molecular assay
Background: Differentiating wild and vaccine measles virus (MeV) strains is critical for appropriate healthcare response during outbreak vaccination campaigns. Sequencing, the current standard, is expensive, time-consuming, and limited t...
03
DOI 10.1093/infdis/jiag516
Open DOI
Activity of a three-phage combination against Mycobacterium tuberculosis in disease-relevant conditions
Background: Phage therapy offers promise to combat antimicrobial resistance, including drug-resistant tuberculosis. Understanding phage activity against Mycobacterium tuberculosis (Mtb) in granuloma-like microenvironments that induce non...
04
DOI 10.1093/infdis/jiag512
Open DOI
In-patient evolution can heterogeneously impact biofilm formation and intraosteoblastic behavior of Staphylococcus aureus in relapsing bone and joint infections
Background: Bone and joint infections caused by Staphylococcus aureus are notoriously difficult to manage and are prone to relapse, often leading to serious clinical complications. Treatment failure is frequently attributed to bacterial ...
05
DOI 10.1093/infdis/jiag503
Open DOI
Proteotyping reactivant toxoplasmic encephalitis reveals virulence-associated dense granule protein GRA5 polymorphisms
Background: A fatal case of toxoplasmic encephalitis has caused microbiologists and clinicians to question whether different strains of Toxoplasma gondii have more pathogenic potential than others. This is concerning, as T. gondii is a w...
06
DOI 10.1093/infdis/jiag514
Open DOI
Inhaled Phosphatidylinositol 4-Kinase Beta (PI4KB) Inhibitor for the Treatment of Experimental Rhinovirus Infection in Patients with Asthma: A Phase 1b Randomized Controlled Study of GSK3923868
Background: Rhinovirus (RV) replication requires the host enzyme, phosphatidylinositol 4-kinase beta (PI4KB). GSK3923868 is an inhibitor of PI4KB being developed to treat RV-associated exacerbations of respiratory disease. The primary ob...
07
DOI 10.1093/infdis/jiag495
Open DOI
Soluble Indicators of Endothelial Injury and Activation Emerge During Acute HIV Infection and Persist Despite Rapid Antiretroviral Therapy Initiation
Background: Vascular activation occurs during human immunodeficiency virus (HIV) infection and is a risk factor for cardiovascular disease (CVD). This study investigates whether vascular endothelial and hemostatic perturbations emerge du...
08
DOI 10.1093/infdis/jiag479
Open DOI
Different Factors Drive Initiation of Gametocytogenesis Versus Gametocyte Carriage in Plasmodium falciparum Infections
Background: Gametocyte carriage varies across Plasmodium falciparum infections. The extent to which this variation reflects differences in the initiation of gametocytogenesis and/or gametocyte maturation remains unclear. We investigated ...
09
DOI 10.1093/infdis/jiag511
Open DOI
Long-term Outcomes in Previously Healthy non-HIV Individuals with Cryptococcal Meningitis Treated with Pulse-taper Corticosteroids for Post-infectious Inflammatory Syndrome
Background: Post-infectious inflammatory response syndrome (PIIRS) is an increasingly recognized complication of cryptococcal meningoencephalitis (CM) in non-HIV infected hosts with significant morbidity and mortality. Data describing lo...
10
Bibliographical & Catalog Notes
NLM copy, bound with this title are its Supplements, no. 1-4, issued May 1905-1909.
Supplements accompany some issues.
Also issued online.
Microfilm. v. 1 (1904)-v. 77 (1945), suppl. 2 (1906) 34 microfilm reels : negative ; 35 mm.
Issued by: the Memorial Institute for Infectious Diseases, 1904-1917; the John McCormick Institute for Infectious Diseases, 1918-19 ; the John Rockefeller McCormick Memorial Fund; and, the Infectious Diseases Society of America, 1969- .
Indexes: Vols. 1-15, 1904-14. 1 v; Vols. 1-50, suppl. 1-4, 1904-32. 1 v.
Vol. 157, no. 1 (JAN 1988)19890818 Notice not published Printed on acid-free paper